nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Intoxication—Hydroxyurea—brain cancer	0.0493	0.0538	CcSEcCtD
Scopolamine—Poisoning—Hydroxyurea—brain cancer	0.0493	0.0538	CcSEcCtD
Scopolamine—Disorientation—Lomustine—brain cancer	0.0219	0.0239	CcSEcCtD
Scopolamine—Photophobia—Procarbazine—brain cancer	0.0161	0.0176	CcSEcCtD
Scopolamine—Paranoia—Carmustine—brain cancer	0.0158	0.0172	CcSEcCtD
Scopolamine—Disorientation—Procarbazine—brain cancer	0.0139	0.0152	CcSEcCtD
Scopolamine—Visual impairment—Lomustine—brain cancer	0.0131	0.0143	CcSEcCtD
Scopolamine—Speech disorder—Carmustine—brain cancer	0.0125	0.0136	CcSEcCtD
Scopolamine—Speech disorder—Temozolomide—brain cancer	0.0121	0.0132	CcSEcCtD
Scopolamine—Disturbance in attention—Temozolomide—brain cancer	0.012	0.0131	CcSEcCtD
Scopolamine—Disorientation—Hydroxyurea—brain cancer	0.0108	0.0118	CcSEcCtD
Scopolamine—Dysphagia—Procarbazine—brain cancer	0.0108	0.0117	CcSEcCtD
Scopolamine—Depressed level of consciousness—Carmustine—brain cancer	0.0104	0.0113	CcSEcCtD
Scopolamine—Depressed level of consciousness—Temozolomide—brain cancer	0.01	0.0109	CcSEcCtD
Scopolamine—Drowsiness—Procarbazine—brain cancer	0.0096	0.0105	CcSEcCtD
Scopolamine—Dry eye—Temozolomide—brain cancer	0.00958	0.0104	CcSEcCtD
Scopolamine—Pain—Carboplatin—brain cancer	0.00943	0.0103	CcSEcCtD
Scopolamine—Sweating—Procarbazine—brain cancer	0.0092	0.01	CcSEcCtD
Scopolamine—Body temperature increased—Carboplatin—brain cancer	0.00871	0.0095	CcSEcCtD
Scopolamine—Hallucination—Procarbazine—brain cancer	0.00857	0.00935	CcSEcCtD
Scopolamine—Amnesia—Carmustine—brain cancer	0.0083	0.00905	CcSEcCtD
Scopolamine—Amnesia—Temozolomide—brain cancer	0.00802	0.00874	CcSEcCtD
Scopolamine—Flushing—Procarbazine—brain cancer	0.008	0.00872	CcSEcCtD
Scopolamine—Thirst—Temozolomide—brain cancer	0.00791	0.00863	CcSEcCtD
Scopolamine—Dysuria—Hydroxyurea—brain cancer	0.00779	0.0085	CcSEcCtD
Scopolamine—Arrhythmia—Procarbazine—brain cancer	0.0077	0.00839	CcSEcCtD
Scopolamine—Body temperature increased—Lomustine—brain cancer	0.00762	0.00831	CcSEcCtD
Scopolamine—SI—head—brain cancer	0.00759	0.0993	CbGeAlD
Scopolamine—Drowsiness—Hydroxyurea—brain cancer	0.00743	0.0081	CcSEcCtD
Scopolamine—Tremor—Procarbazine—brain cancer	0.00703	0.00766	CcSEcCtD
Scopolamine—SI—central nervous system—brain cancer	0.00693	0.0907	CbGeAlD
Scopolamine—Dry skin—Temozolomide—brain cancer	0.0069	0.00753	CcSEcCtD
Scopolamine—Muscular weakness—Carmustine—brain cancer	0.00687	0.0075	CcSEcCtD
Scopolamine—Dysphagia—Carmustine—brain cancer	0.00674	0.00734	CcSEcCtD
Scopolamine—Muscular weakness—Temozolomide—brain cancer	0.00664	0.00724	CcSEcCtD
Scopolamine—Hallucination—Hydroxyurea—brain cancer	0.00664	0.00724	CcSEcCtD
Scopolamine—Dysphagia—Temozolomide—brain cancer	0.00651	0.0071	CcSEcCtD
Scopolamine—Dry mouth—Procarbazine—brain cancer	0.00625	0.00681	CcSEcCtD
Scopolamine—Confusional state—Procarbazine—brain cancer	0.00617	0.00673	CcSEcCtD
Scopolamine—Vomiting—Lomustine—brain cancer	0.00613	0.00669	CcSEcCtD
Scopolamine—Oedema—Procarbazine—brain cancer	0.00612	0.00668	CcSEcCtD
Scopolamine—Dysuria—Temozolomide—brain cancer	0.00609	0.00664	CcSEcCtD
Scopolamine—Tachycardia—Procarbazine—brain cancer	0.00598	0.00652	CcSEcCtD
Scopolamine—Hyperhidrosis—Procarbazine—brain cancer	0.00592	0.00645	CcSEcCtD
Scopolamine—Erythema—Hydroxyurea—brain cancer	0.00581	0.00633	CcSEcCtD
Scopolamine—Nausea—Lomustine—brain cancer	0.00573	0.00625	CcSEcCtD
Scopolamine—Hypotension—Procarbazine—brain cancer	0.00572	0.00624	CcSEcCtD
Scopolamine—SI—brain—brain cancer	0.0055	0.072	CbGeAlD
Scopolamine—Somnolence—Procarbazine—brain cancer	0.00544	0.00594	CcSEcCtD
Scopolamine—Hallucination—Carmustine—brain cancer	0.00536	0.00585	CcSEcCtD
Scopolamine—Fatigue—Procarbazine—brain cancer	0.00528	0.00576	CcSEcCtD
Scopolamine—Constipation—Procarbazine—brain cancer	0.00524	0.00571	CcSEcCtD
Scopolamine—Pain—Procarbazine—brain cancer	0.00524	0.00571	CcSEcCtD
Scopolamine—Dysphagia—Etoposide—brain cancer	0.00521	0.00568	CcSEcCtD
Scopolamine—Visual impairment—Carmustine—brain cancer	0.0052	0.00567	CcSEcCtD
Scopolamine—Hallucination—Temozolomide—brain cancer	0.00518	0.00565	CcSEcCtD
Scopolamine—Pharyngitis—Temozolomide—brain cancer	0.00517	0.00564	CcSEcCtD
Scopolamine—Urinary tract disorder—Temozolomide—brain cancer	0.00515	0.00561	CcSEcCtD
Scopolamine—Urethral disorder—Temozolomide—brain cancer	0.00511	0.00557	CcSEcCtD
Scopolamine—Feeling abnormal—Procarbazine—brain cancer	0.00505	0.0055	CcSEcCtD
Scopolamine—Eye disorder—Carmustine—brain cancer	0.00504	0.00549	CcSEcCtD
Scopolamine—Visual impairment—Temozolomide—brain cancer	0.00502	0.00548	CcSEcCtD
Scopolamine—Flushing—Carmustine—brain cancer	0.005	0.00546	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00491	0.00535	CcSEcCtD
Scopolamine—Eye disorder—Temozolomide—brain cancer	0.00487	0.00531	CcSEcCtD
Scopolamine—Abdominal pain—Procarbazine—brain cancer	0.00484	0.00528	CcSEcCtD
Scopolamine—Body temperature increased—Procarbazine—brain cancer	0.00484	0.00528	CcSEcCtD
Scopolamine—Flushing—Temozolomide—brain cancer	0.00484	0.00527	CcSEcCtD
Scopolamine—Arrhythmia—Carmustine—brain cancer	0.00482	0.00525	CcSEcCtD
Scopolamine—Oedema—Hydroxyurea—brain cancer	0.00474	0.00517	CcSEcCtD
Scopolamine—Mental disorder—Carmustine—brain cancer	0.00472	0.00515	CcSEcCtD
Scopolamine—Erythema—Carmustine—brain cancer	0.00469	0.00512	CcSEcCtD
Scopolamine—Nervous system disorder—Hydroxyurea—brain cancer	0.00465	0.00507	CcSEcCtD
Scopolamine—Skin disorder—Hydroxyurea—brain cancer	0.0046	0.00502	CcSEcCtD
Scopolamine—Mental disorder—Temozolomide—brain cancer	0.00456	0.00498	CcSEcCtD
Scopolamine—Erythema—Temozolomide—brain cancer	0.00454	0.00495	CcSEcCtD
Scopolamine—Vision blurred—Carmustine—brain cancer	0.00442	0.00482	CcSEcCtD
Scopolamine—Tremor—Carmustine—brain cancer	0.0044	0.00479	CcSEcCtD
Scopolamine—Asthenia—Procarbazine—brain cancer	0.00439	0.00479	CcSEcCtD
Scopolamine—Pruritus—Procarbazine—brain cancer	0.00433	0.00472	CcSEcCtD
Scopolamine—Agitation—Carmustine—brain cancer	0.00431	0.0047	CcSEcCtD
Scopolamine—Vision blurred—Temozolomide—brain cancer	0.00427	0.00466	CcSEcCtD
Scopolamine—Tremor—Temozolomide—brain cancer	0.00425	0.00463	CcSEcCtD
Scopolamine—Somnolence—Hydroxyurea—brain cancer	0.00421	0.00459	CcSEcCtD
Scopolamine—Agitation—Temozolomide—brain cancer	0.00417	0.00455	CcSEcCtD
Scopolamine—Urinary tract disorder—Etoposide—brain cancer	0.00412	0.00449	CcSEcCtD
Scopolamine—Urethral disorder—Etoposide—brain cancer	0.00409	0.00446	CcSEcCtD
Scopolamine—Fatigue—Hydroxyurea—brain cancer	0.00409	0.00445	CcSEcCtD
Scopolamine—Vertigo—Temozolomide—brain cancer	0.00408	0.00444	CcSEcCtD
Scopolamine—Pain—Hydroxyurea—brain cancer	0.00405	0.00442	CcSEcCtD
Scopolamine—Constipation—Hydroxyurea—brain cancer	0.00405	0.00442	CcSEcCtD
Scopolamine—Dizziness—Procarbazine—brain cancer	0.00405	0.00441	CcSEcCtD
Scopolamine—Feeling abnormal—Hydroxyurea—brain cancer	0.0039	0.00426	CcSEcCtD
Scopolamine—Eye disorder—Etoposide—brain cancer	0.0039	0.00425	CcSEcCtD
Scopolamine—Vomiting—Procarbazine—brain cancer	0.00389	0.00424	CcSEcCtD
Scopolamine—Flushing—Etoposide—brain cancer	0.00387	0.00422	CcSEcCtD
Scopolamine—Confusional state—Carmustine—brain cancer	0.00386	0.00421	CcSEcCtD
Scopolamine—Rash—Procarbazine—brain cancer	0.00386	0.00421	CcSEcCtD
Scopolamine—Dermatitis—Procarbazine—brain cancer	0.00386	0.00421	CcSEcCtD
Scopolamine—Headache—Procarbazine—brain cancer	0.00384	0.00418	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00383	0.00418	CcSEcCtD
Scopolamine—Oedema—Carmustine—brain cancer	0.00383	0.00418	CcSEcCtD
Scopolamine—Dry mouth—Temozolomide—brain cancer	0.00378	0.00412	CcSEcCtD
Scopolamine—CHRM4—head—brain cancer	0.00375	0.0491	CbGeAlD
Scopolamine—Body temperature increased—Hydroxyurea—brain cancer	0.00375	0.00408	CcSEcCtD
Scopolamine—Tachycardia—Carmustine—brain cancer	0.00374	0.00408	CcSEcCtD
Scopolamine—Confusional state—Temozolomide—brain cancer	0.00373	0.00407	CcSEcCtD
Scopolamine—Oedema—Temozolomide—brain cancer	0.0037	0.00404	CcSEcCtD
Scopolamine—Nausea—Procarbazine—brain cancer	0.00364	0.00397	CcSEcCtD
Scopolamine—Nervous system disorder—Temozolomide—brain cancer	0.00363	0.00396	CcSEcCtD
Scopolamine—Skin disorder—Temozolomide—brain cancer	0.0036	0.00392	CcSEcCtD
Scopolamine—Hypotension—Carmustine—brain cancer	0.00358	0.0039	CcSEcCtD
Scopolamine—Hyperhidrosis—Temozolomide—brain cancer	0.00358	0.0039	CcSEcCtD
Scopolamine—CHRM4—central nervous system—brain cancer	0.00342	0.0448	CbGeAlD
Scopolamine—Somnolence—Carmustine—brain cancer	0.00341	0.00371	CcSEcCtD
Scopolamine—Asthenia—Hydroxyurea—brain cancer	0.0034	0.00371	CcSEcCtD
Scopolamine—Somnolence—Temozolomide—brain cancer	0.00329	0.00359	CcSEcCtD
Scopolamine—Pain—Carmustine—brain cancer	0.00328	0.00357	CcSEcCtD
Scopolamine—Constipation—Carmustine—brain cancer	0.00328	0.00357	CcSEcCtD
Scopolamine—Vertigo—Etoposide—brain cancer	0.00326	0.00356	CcSEcCtD
Scopolamine—CHRM2—telencephalon—brain cancer	0.00323	0.0423	CbGeAlD
Scopolamine—Fatigue—Temozolomide—brain cancer	0.00319	0.00348	CcSEcCtD
Scopolamine—Pain—Temozolomide—brain cancer	0.00317	0.00345	CcSEcCtD
Scopolamine—Constipation—Temozolomide—brain cancer	0.00317	0.00345	CcSEcCtD
Scopolamine—Feeling abnormal—Carmustine—brain cancer	0.00316	0.00344	CcSEcCtD
Scopolamine—Dizziness—Hydroxyurea—brain cancer	0.00313	0.00342	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00307	0.00335	CcSEcCtD
Scopolamine—Feeling abnormal—Temozolomide—brain cancer	0.00305	0.00333	CcSEcCtD
Scopolamine—Body temperature increased—Carmustine—brain cancer	0.00303	0.0033	CcSEcCtD
Scopolamine—Abdominal pain—Carmustine—brain cancer	0.00303	0.0033	CcSEcCtD
Scopolamine—Vomiting—Hydroxyurea—brain cancer	0.00301	0.00329	CcSEcCtD
Scopolamine—Rash—Hydroxyurea—brain cancer	0.00299	0.00326	CcSEcCtD
Scopolamine—Confusional state—Etoposide—brain cancer	0.00299	0.00326	CcSEcCtD
Scopolamine—Dermatitis—Hydroxyurea—brain cancer	0.00298	0.00325	CcSEcCtD
Scopolamine—Headache—Hydroxyurea—brain cancer	0.00297	0.00324	CcSEcCtD
Scopolamine—CHRM1—telencephalon—brain cancer	0.00294	0.0385	CbGeAlD
Scopolamine—CHRM5—head—brain cancer	0.00293	0.0383	CbGeAlD
Scopolamine—Body temperature increased—Temozolomide—brain cancer	0.00293	0.00319	CcSEcCtD
Scopolamine—Abdominal pain—Temozolomide—brain cancer	0.00293	0.00319	CcSEcCtD
Scopolamine—Tachycardia—Etoposide—brain cancer	0.00289	0.00315	CcSEcCtD
Scopolamine—Skin disorder—Etoposide—brain cancer	0.00288	0.00314	CcSEcCtD
Scopolamine—Hyperhidrosis—Etoposide—brain cancer	0.00286	0.00312	CcSEcCtD
Scopolamine—Nausea—Hydroxyurea—brain cancer	0.00281	0.00307	CcSEcCtD
Scopolamine—Hypotension—Etoposide—brain cancer	0.00277	0.00302	CcSEcCtD
Scopolamine—Asthenia—Carmustine—brain cancer	0.00275	0.003	CcSEcCtD
Scopolamine—CHRM4—brain—brain cancer	0.00272	0.0356	CbGeAlD
Scopolamine—CHRM5—central nervous system—brain cancer	0.00268	0.035	CbGeAlD
Scopolamine—Asthenia—Temozolomide—brain cancer	0.00266	0.0029	CcSEcCtD
Scopolamine—Somnolence—Etoposide—brain cancer	0.00263	0.00287	CcSEcCtD
Scopolamine—CHRM3—telencephalon—brain cancer	0.00263	0.0344	CbGeAlD
Scopolamine—Pruritus—Temozolomide—brain cancer	0.00262	0.00286	CcSEcCtD
Scopolamine—Fatigue—Etoposide—brain cancer	0.00255	0.00278	CcSEcCtD
Scopolamine—Dizziness—Carmustine—brain cancer	0.00253	0.00276	CcSEcCtD
Scopolamine—Pain—Etoposide—brain cancer	0.00253	0.00276	CcSEcCtD
Scopolamine—Constipation—Etoposide—brain cancer	0.00253	0.00276	CcSEcCtD
Scopolamine—Dizziness—Temozolomide—brain cancer	0.00245	0.00267	CcSEcCtD
Scopolamine—Feeling abnormal—Etoposide—brain cancer	0.00244	0.00266	CcSEcCtD
Scopolamine—Vomiting—Carmustine—brain cancer	0.00244	0.00266	CcSEcCtD
Scopolamine—Rash—Carmustine—brain cancer	0.00242	0.00263	CcSEcCtD
Scopolamine—Dermatitis—Carmustine—brain cancer	0.00241	0.00263	CcSEcCtD
Scopolamine—Headache—Carmustine—brain cancer	0.0024	0.00262	CcSEcCtD
Scopolamine—Vomiting—Temozolomide—brain cancer	0.00235	0.00257	CcSEcCtD
Scopolamine—Abdominal pain—Etoposide—brain cancer	0.00234	0.00255	CcSEcCtD
Scopolamine—Body temperature increased—Etoposide—brain cancer	0.00234	0.00255	CcSEcCtD
Scopolamine—Rash—Temozolomide—brain cancer	0.00233	0.00255	CcSEcCtD
Scopolamine—Dermatitis—Temozolomide—brain cancer	0.00233	0.00254	CcSEcCtD
Scopolamine—Headache—Temozolomide—brain cancer	0.00232	0.00253	CcSEcCtD
Scopolamine—Nausea—Carmustine—brain cancer	0.00228	0.00248	CcSEcCtD
Scopolamine—Nausea—Temozolomide—brain cancer	0.0022	0.0024	CcSEcCtD
Scopolamine—Asthenia—Etoposide—brain cancer	0.00213	0.00232	CcSEcCtD
Scopolamine—CHRM5—brain—brain cancer	0.00212	0.0278	CbGeAlD
Scopolamine—ABCB1—blood vessel—brain cancer	0.00211	0.0276	CbGeAlD
Scopolamine—Pruritus—Etoposide—brain cancer	0.0021	0.00229	CcSEcCtD
Scopolamine—CHRM2—endocrine gland—brain cancer	0.00204	0.0267	CbGeAlD
Scopolamine—CHRM2—head—brain cancer	0.00201	0.0263	CbGeAlD
Scopolamine—Dizziness—Etoposide—brain cancer	0.00196	0.00214	CcSEcCtD
Scopolamine—Vomiting—Etoposide—brain cancer	0.00188	0.00205	CcSEcCtD
Scopolamine—Rash—Etoposide—brain cancer	0.00187	0.00204	CcSEcCtD
Scopolamine—Dermatitis—Etoposide—brain cancer	0.00187	0.00203	CcSEcCtD
Scopolamine—Headache—Etoposide—brain cancer	0.00186	0.00202	CcSEcCtD
Scopolamine—CHRM1—endocrine gland—brain cancer	0.00186	0.0243	CbGeAlD
Scopolamine—CHRM2—central nervous system—brain cancer	0.00184	0.024	CbGeAlD
Scopolamine—CHRM1—head—brain cancer	0.00183	0.024	CbGeAlD
Scopolamine—Nausea—Etoposide—brain cancer	0.00176	0.00192	CcSEcCtD
Scopolamine—CHRM1—central nervous system—brain cancer	0.00167	0.0219	CbGeAlD
Scopolamine—CHRM3—endocrine gland—brain cancer	0.00166	0.0217	CbGeAlD
Scopolamine—CHRM3—head—brain cancer	0.00164	0.0214	CbGeAlD
Scopolamine—CHRM3—central nervous system—brain cancer	0.0015	0.0196	CbGeAlD
Scopolamine—CHRM2—brain—brain cancer	0.00146	0.0191	CbGeAlD
Scopolamine—CHRM1—brain—brain cancer	0.00133	0.0174	CbGeAlD
Scopolamine—CHRM3—brain—brain cancer	0.00119	0.0155	CbGeAlD
Scopolamine—ABCB1—telencephalon—brain cancer	0.00102	0.0134	CbGeAlD
Scopolamine—ABCB1—gonad—brain cancer	0.000855	0.0112	CbGeAlD
Scopolamine—ABCB1—pituitary gland—brain cancer	0.000834	0.0109	CbGeAlD
Scopolamine—ABCB1—medulla oblongata—brain cancer	0.000804	0.0105	CbGeAlD
Scopolamine—ABCB1—midbrain—brain cancer	0.000735	0.00962	CbGeAlD
Scopolamine—ABCB1—spinal cord—brain cancer	0.000717	0.00938	CbGeAlD
Scopolamine—ABCB1—endocrine gland—brain cancer	0.000646	0.00845	CbGeAlD
Scopolamine—ABCB1—head—brain cancer	0.000638	0.00834	CbGeAlD
Scopolamine—ABCB1—central nervous system—brain cancer	0.000582	0.00761	CbGeAlD
Scopolamine—ABCB1—cerebellum—brain cancer	0.000569	0.00744	CbGeAlD
Scopolamine—ABCB1—brain—brain cancer	0.000462	0.00604	CbGeAlD
Scopolamine—CHRM5—GPCR downstream signaling—TRPC6—brain cancer	1.32e-05	0.00205	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ABR—brain cancer	1.32e-05	0.00205	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DTX2—brain cancer	1.31e-05	0.00203	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—SHH—brain cancer	1.3e-05	0.00202	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TRPC6—brain cancer	1.26e-05	0.00195	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.25e-05	0.00194	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—SHH—brain cancer	1.25e-05	0.00193	CbGpPWpGaD
Scopolamine—SI—Disease—STAT3—brain cancer	1.24e-05	0.00192	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PTCH1—brain cancer	1.23e-05	0.00191	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—SMO—brain cancer	1.23e-05	0.00191	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	1.21e-05	0.00187	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TRPC6—brain cancer	1.2e-05	0.00186	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.19e-05	0.00184	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PTCH1—brain cancer	1.18e-05	0.00183	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—SMO—brain cancer	1.18e-05	0.00183	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.17e-05	0.00182	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ABR—brain cancer	1.17e-05	0.00182	CbGpPWpGaD
Scopolamine—SI—Disease—MYC—brain cancer	1.15e-05	0.00178	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GLI2—brain cancer	1.13e-05	0.00175	CbGpPWpGaD
Scopolamine—SI—Disease—EGFR—brain cancer	1.12e-05	0.00174	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ABR—brain cancer	1.12e-05	0.00174	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GLI2—brain cancer	1.08e-05	0.00168	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP2C9—brain cancer	1.07e-05	0.00166	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GLI1—brain cancer	1.06e-05	0.00165	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.06e-05	0.00165	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	1.06e-05	0.00165	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—VAV1—brain cancer	1.04e-05	0.00161	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.03e-05	0.00159	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GLI1—brain cancer	1.02e-05	0.00158	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SUFU—brain cancer	1.01e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTCH2—brain cancer	1.01e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTCH2—brain cancer	1e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1e-05	0.00155	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTCH2—brain cancer	9.94e-06	0.00154	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—VAV1—brain cancer	9.92e-06	0.00154	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	9.91e-06	0.00154	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HES5—brain cancer	9.75e-06	0.00151	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GFAP—brain cancer	9.73e-06	0.00151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HES5—brain cancer	9.72e-06	0.00151	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	9.68e-06	0.0015	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SUFU—brain cancer	9.66e-06	0.0015	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HES5—brain cancer	9.62e-06	0.00149	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STRADA—brain cancer	9.46e-06	0.00147	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STRADA—brain cancer	9.43e-06	0.00146	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—VAV1—brain cancer	9.41e-06	0.00146	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STRADA—brain cancer	9.34e-06	0.00145	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	9.32e-06	0.00145	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GFAP—brain cancer	9.32e-06	0.00145	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	9.29e-06	0.00144	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HEY1—brain cancer	9.22e-06	0.00143	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	9.2e-06	0.00143	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—BSG—brain cancer	9.1e-06	0.00141	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DLL1—brain cancer	9.05e-06	0.0014	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—VAV1—brain cancer	9.01e-06	0.0014	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HEY1—brain cancer	8.83e-06	0.00137	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—SHH—brain cancer	8.78e-06	0.00136	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—SHH—brain cancer	8.75e-06	0.00136	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—SHH—brain cancer	8.67e-06	0.00134	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DLL1—brain cancer	8.66e-06	0.00134	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TRPC6—brain cancer	8.47e-06	0.00131	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TRPC6—brain cancer	8.44e-06	0.00131	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	8.36e-06	0.0013	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—SMO—brain cancer	8.32e-06	0.00129	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	8.32e-06	0.00129	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—SMO—brain cancer	8.3e-06	0.00129	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTCH1—brain cancer	8.3e-06	0.00129	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	8.22e-06	0.00127	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—SMO—brain cancer	8.22e-06	0.00127	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.08e-06	0.00125	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ABR—brain cancer	7.9e-06	0.00123	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ABR—brain cancer	7.87e-06	0.00122	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—IDH1—brain cancer	7.82e-06	0.00121	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ABR—brain cancer	7.8e-06	0.00121	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SHH—brain cancer	7.69e-06	0.00119	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GLI2—brain cancer	7.63e-06	0.00118	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GLI2—brain cancer	7.61e-06	0.00118	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GLI2—brain cancer	7.53e-06	0.00117	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.51e-06	0.00117	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.49e-06	0.00116	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.47e-06	0.00116	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TRPC6—brain cancer	7.42e-06	0.00115	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SHH—brain cancer	7.37e-06	0.00114	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SMO—brain cancer	7.29e-06	0.00113	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTCH1—brain cancer	7.29e-06	0.00113	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GLI1—brain cancer	7.17e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GLI1—brain cancer	7.15e-06	0.00111	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TRPC6—brain cancer	7.1e-06	0.0011	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GLI1—brain cancer	7.08e-06	0.0011	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	6.98e-06	0.00108	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SMO—brain cancer	6.98e-06	0.00108	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTCH1—brain cancer	6.98e-06	0.00108	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	6.96e-06	0.00108	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	6.89e-06	0.00107	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SUFU—brain cancer	6.8e-06	0.00105	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2C9—brain cancer	6.79e-06	0.00105	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SUFU—brain cancer	6.78e-06	0.00105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SUFU—brain cancer	6.71e-06	0.00104	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.64e-06	0.00103	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—brain cancer	6.64e-06	0.00103	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	6.58e-06	0.00102	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.57e-06	0.00102	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GFAP—brain cancer	6.56e-06	0.00102	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GFAP—brain cancer	6.54e-06	0.00101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GFAP—brain cancer	6.48e-06	0.001	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—VAV1—brain cancer	6.34e-06	0.000984	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—VAV1—brain cancer	6.32e-06	0.000981	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	6.3e-06	0.000977	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—VAV1—brain cancer	6.26e-06	0.000971	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HEY1—brain cancer	6.22e-06	0.000965	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HEY1—brain cancer	6.2e-06	0.000962	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ENO2—brain cancer	6.18e-06	0.000959	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HEY1—brain cancer	6.14e-06	0.000952	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DLL1—brain cancer	6.1e-06	0.000946	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DLL1—brain cancer	6.08e-06	0.000943	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DLL1—brain cancer	6.02e-06	0.000934	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	5.97e-06	0.000926	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOTCH2—brain cancer	5.83e-06	0.000904	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.79e-06	0.000898	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—BSG—brain cancer	5.77e-06	0.000895	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	5.72e-06	0.000887	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOTCH2—brain cancer	5.58e-06	0.000866	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VAV1—brain cancer	5.56e-06	0.000862	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.32e-06	0.000826	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VAV1—brain cancer	5.32e-06	0.000825	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.21e-06	0.000808	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SHH—brain cancer	5.19e-06	0.000804	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SHH—brain cancer	5.17e-06	0.000802	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SHH—brain cancer	5.12e-06	0.000794	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TRPC6—brain cancer	5e-06	0.000776	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TRPC6—brain cancer	4.98e-06	0.000773	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—IDH1—brain cancer	4.96e-06	0.00077	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TRPC6—brain cancer	4.94e-06	0.000766	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTCH1—brain cancer	4.92e-06	0.000762	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SMO—brain cancer	4.92e-06	0.000762	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTCH1—brain cancer	4.9e-06	0.00076	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SMO—brain cancer	4.9e-06	0.00076	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTCH1—brain cancer	4.85e-06	0.000753	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SMO—brain cancer	4.85e-06	0.000753	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HES1—brain cancer	4.78e-06	0.000741	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL2—brain cancer	4.63e-06	0.000718	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HES1—brain cancer	4.58e-06	0.00071	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PDGFRA—brain cancer	4.55e-06	0.000706	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	4.43e-06	0.000688	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL2—brain cancer	4.43e-06	0.000687	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	4.42e-06	0.000686	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SPP1—brain cancer	4.42e-06	0.000685	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	4.38e-06	0.000679	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.37e-06	0.000678	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PDGFRA—brain cancer	4.36e-06	0.000676	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPP1—brain cancer	4.23e-06	0.000656	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL2—brain cancer	4.2e-06	0.000652	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	4.03e-06	0.000625	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL2—brain cancer	4.02e-06	0.000624	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	4.01e-06	0.000623	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IRS2—brain cancer	3.99e-06	0.00062	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	3.98e-06	0.000617	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	3.93e-06	0.00061	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ENO2—brain cancer	3.92e-06	0.000608	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	3.92e-06	0.000608	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	3.88e-06	0.000602	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IRS2—brain cancer	3.83e-06	0.000593	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VAV1—brain cancer	3.75e-06	0.000581	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VAV1—brain cancer	3.73e-06	0.000579	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VAV1—brain cancer	3.7e-06	0.000574	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APC—brain cancer	3.53e-06	0.000547	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	3.53e-06	0.000547	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	3.38e-06	0.000524	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APC—brain cancer	3.38e-06	0.000524	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HES1—brain cancer	3.22e-06	0.0005	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EGFR—brain cancer	3.21e-06	0.000499	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HES1—brain cancer	3.21e-06	0.000498	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HES1—brain cancer	3.18e-06	0.000493	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL2—brain cancer	3.12e-06	0.000484	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL2—brain cancer	3.11e-06	0.000482	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL2—brain cancer	3.08e-06	0.000478	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EGFR—brain cancer	3.08e-06	0.000477	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	3.07e-06	0.000476	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	3.06e-06	0.000474	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	3.03e-06	0.00047	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPP1—brain cancer	2.98e-06	0.000462	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPP1—brain cancer	2.97e-06	0.00046	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPP1—brain cancer	2.94e-06	0.000456	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CG—brain cancer	2.84e-06	0.00044	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL2—brain cancer	2.83e-06	0.00044	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL2—brain cancer	2.82e-06	0.000438	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL2—brain cancer	2.8e-06	0.000434	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RELA—brain cancer	2.76e-06	0.000428	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ERBB2—brain cancer	2.74e-06	0.000425	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS2—brain cancer	2.69e-06	0.000418	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS2—brain cancer	2.69e-06	0.000416	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS2—brain cancer	2.66e-06	0.000412	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RELA—brain cancer	2.64e-06	0.000409	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ERBB2—brain cancer	2.62e-06	0.000407	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL2—brain cancer	2.48e-06	0.000385	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—brain cancer	2.42e-06	0.000375	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	2.4e-06	0.000372	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APC—brain cancer	2.38e-06	0.000369	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	2.38e-06	0.000369	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL2—brain cancer	2.38e-06	0.000369	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	2.37e-06	0.000368	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APC—brain cancer	2.37e-06	0.000368	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APC—brain cancer	2.35e-06	0.000364	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	2.35e-06	0.000364	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—brain cancer	2.32e-06	0.000359	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	2.3e-06	0.000356	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EGFR—brain cancer	2.17e-06	0.000336	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EGFR—brain cancer	2.16e-06	0.000335	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EGFR—brain cancer	2.14e-06	0.000332	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—brain cancer	2.11e-06	0.000327	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—brain cancer	2.09e-06	0.000324	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—brain cancer	2.02e-06	0.000313	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—brain cancer	2e-06	0.00031	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—brain cancer	1.94e-06	0.000301	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGFR—brain cancer	1.9e-06	0.000295	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—brain cancer	1.86e-06	0.000288	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RELA—brain cancer	1.86e-06	0.000288	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RELA—brain cancer	1.85e-06	0.000287	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ERBB2—brain cancer	1.85e-06	0.000286	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ERBB2—brain cancer	1.84e-06	0.000286	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RELA—brain cancer	1.83e-06	0.000285	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ERBB2—brain cancer	1.82e-06	0.000283	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGFR—brain cancer	1.82e-06	0.000282	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CG—brain cancer	1.8e-06	0.000279	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL2—brain cancer	1.67e-06	0.00026	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL2—brain cancer	1.67e-06	0.000259	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL2—brain cancer	1.65e-06	0.000256	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—brain cancer	1.63e-06	0.000253	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—brain cancer	1.63e-06	0.000252	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	1.62e-06	0.000251	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—brain cancer	1.61e-06	0.00025	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	1.61e-06	0.00025	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	1.6e-06	0.000247	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—brain cancer	1.59e-06	0.000247	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—brain cancer	1.53e-06	0.000237	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—brain cancer	1.42e-06	0.000221	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—brain cancer	1.42e-06	0.00022	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—brain cancer	1.41e-06	0.000218	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—brain cancer	1.4e-06	0.000218	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—brain cancer	1.4e-06	0.000218	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—brain cancer	1.39e-06	0.000216	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—brain cancer	1.31e-06	0.000203	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—brain cancer	1.3e-06	0.000202	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—brain cancer	1.29e-06	0.0002	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGFR—brain cancer	1.28e-06	0.000199	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGFR—brain cancer	1.28e-06	0.000198	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGFR—brain cancer	1.26e-06	0.000196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—brain cancer	1.08e-06	0.000167	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—brain cancer	1.07e-06	0.000166	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—brain cancer	1.06e-06	0.000165	CbGpPWpGaD
